Stocks and Investing
Stocks and Investing
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Louise Chen Reiterated (zvra) at Buy on, Aug 14th, 2024
Louise Chen of Cantor Fitzgerald, Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Buy on, Aug 14th, 2024.
Louise has made no other calls on ZVRA in the last 4 months.
There is 1 other peer that has a rating on ZVRA. Out of the 1 peers that are also analyzing ZVRA, 0 agree with Louise's Rating of Hold.
This is the rating of the analyst that currently disagrees with Louise
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Monday, August 5th, 2024
Contributing Sources